MarketInOut Stock Screener Log In | Sign Up
 

Generate Biomedicines Inc

NASDAQ • Healthcare • Biotechnology • Quote as of 10/09/2026
Generate Biomedicines Inc stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization1,771.26 mln
Float55.21 mln
Earnings Date11/05/2026

1-Year Forecast

27.00
Transformational upside

Relative Strength

24 / 100
Significantly lagging

Debt / Equity

0.14
Very low leverage

Pre-Tax Margin

-952%
Severely loss-making

ROE

-26.51
Deeply negative

Altman Z-Score

9.3
Exceptional

Business Description

Generate Biomedicines is a biotechnology company based in Somerville, Massachusetts, that uses machine learning to design and develop new protein-based medicines. The company is advancing several drug candidates, including treatments targeting severe asthma, cancer, and other serious conditions. Its proprietary platform combines advanced computing with laboratory technology to create therapies that would be difficult or impossible to develop using conventional methods. Founded in 2018, the company aims to push the boundaries of what modern medicine can achieve.

Key Fundamentals

EPS-2.44
ROE-26.51
RPS0.32
ROIC-106
ROA-21.68
Interest Cover-403
EBITDA, mln-122
EV / EBITDA-12.62
EV / EBIT-11.99
Revenue, mln13.54
EV / Revenue114

Quote Details

Last 14.34
Change 0.35 (2.5%)
Open 14.06
Volume 903,081
Turnover 12,950,182
Average Volume 1,212,672

Financial Ratios

Pre-Tax Profit Margin-952
Leverage Ratio1.23
Current Ratio8.30
Price / Book4.24
Price / Tangible Book4.24
Debt / Equity0.14
Price / Sales144

Financial Strength

Altman Z-Score9.3
1-Year Target Price27.00
Short Ratio4.66
Short % of Float9.60

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 4.75% 91 / 100   
1 Month -6.82% 26 / 100   
2 Months -15.25% 25 / 100   
6 Months 25.68% 87 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Contact Us